Skip to content

On-X Ascending Aortic Prosthesis ONXAAP-27/29Recalls & reported problems

On-X Life Technologies, Inc. · Bileaflet mechanical heart valve attached to a vascular prosthesis implanted in the aortic position · Class 3 · Implant

All models of On-X Ascending Aortic Prosthesis (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
12
Deaths reported
1
Injuries reported
11
Recalls naming it
0

Summary

The FDA's MAUDE database contains 12 adverse event reports that list this exact device (DI 00851788001549), received between Oct 24, 2022 and Jun 6, 2025 — classified as 1 death, 11 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).

4 other recalls cover devices cleared under the same FDA submission (P000037); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 2 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem11
  • Insufficient Device Problem Information2

Patient problems

  • Arrhythmia3
  • Endocarditis2
  • Insufficient Information2
  • Unspecified Heart Problem2
  • Convulsion/Seizure1
  • Heart Block1
  • Hematoma1
  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 12 most recent of 12 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED VIA EMAIL ON 07MAY2025 FROM A HOSPITAL REPORT INDICATING THE ON-X VALVE HAD BEEN EXPLANTED. THIS INVESTIGATION IS RELEGATED TO ONXAPP 27/29 SERIAL NUMBER: (B)(6) WITH THE ALLEGATION OF EXPLANT.

    Patient problems: Unspecified Heart Problem

    MAUDE report 22160818 ↗
  • InjuryJun 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED VIA EMAIL ON (B)(6) 2025 A HOSPITAL REPORT INDICATING THE ON-X VALVE HAD BEEN EXPLANTED. THIS INVESTIGATION IS RELEGATED TO ONXAPP 27/29 SERIAL NUMBER: (B)(6) WITH THE ALLEGATION OF EXPLANT.

    Patient problems: Unspecified Heart Problem

    MAUDE report 22157877 ↗
  • InjuryNov 14, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT THE HOSPITAL REPORTED AN EXPLANT OF AN ON-X VALVE AND A REPLACEMENT IMPLANT OF AN ON-X VALVE FOR THE SAME PATIENT.

    Patient problems: Endocarditis; Insufficient Information

    MAUDE report 20689131 ↗
  • DeathSep 30, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT, PATIENT IN THE ASCEND STUDY PASSED AWAY ON (B)(6) 2023. THIS EVENT IS LISTED AS POSSIBLY RELATED TO THE PROCEDURE, DEVICE AND/OR AORTIC VALVE DISEASE.

    Patient problems: Insufficient Information

    MAUDE report 20339957 ↗
  • InjuryJul 19, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT, SURGEON HAD FOUR PATIENTS RECENTLY THAT RECEIVED ONXAAPS END UP WITH INFECTIONS. TWO REQUIRED TAKE BACK TO THE OPERATING ROOM FOR WASHOUT DUE TO PERICARDIAL EFFUSIONS/MEDIASTINAL FLUID COLLECTIONS. SWABS WERE TAKEN OF THE MEDIASTINAL FLUID AND DID NOT GROW ANY ORGANISMS. ALL FOUR PATIENTS HAD ELEVATED WBC [WHITE BLOOD CELL] COUNTS. INDIUM NUCLEAR WBC SCAN WERE POSITIVE ON ALL FOUR WITH UPTAKE AROUND THE AORTA. THIS INVESTIGATION IS RELEGATED TO ONE OF THE FOUR PATIENTS WITH DATE OF IMPLANT: (B)(6) 2023.

    Patient problems: Endocarditis; Pericardial Effusion; Unspecified Infection

    MAUDE report 17350622 ↗
  • InjuryApr 26, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    ACCORDING TO AAP STUDY - ASCEND - POST MARKET CLINICAL FOLLOW-UP STUDY IN PATIENTS TREATED WITH THE ON-X ASCENDING AORTIC PROSTHESIS (AAP) ADVERSE EVENT REPORT, PATIENT EXPERIENCED MAJOR BLEEDING EVENT (B)(6) 2023. DATE OF IMPLANT: (B)(6) 2023. LED TO A SERIOUS DETERIORATION IN THE HEALTH OF THE SUBJECT, USERS OR OTHER PERSONS AS DEFINED BY ONE OF THE FOLLOWING: MEDICAL OR SURGICAL INTERVENTION TO PREVENT LIFE-THREATENING ILLNESS OR INJURY OR PERMANENT IMPAIRMENT TO A BODY STRUCTURE OR BODY FUNCTION. START DATE: (B)(6) 2023. END DATE: (B)(6) 2023. SYMPTOMS RESOLVED WITHOUT SEQUELAE. CAUSAL RELATIONSHIP TO PROCEDURE: CAUSAL. CAUSAL RELATIONSHIP TO THE AORTIC VALVE DISEASE OF HETEROGENEOUS ETHOLOGY: NOT RELATED. CAUSAL RELATIONSHIP TO ONXAAP: POSSIBLE. NUMBER OF REOPERATIONS PERFORMED: 1.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 16818120 ↗
  • InjuryMar 7, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED, PATIENT IN THE STUDY EXPERIENCED CARDIAC ARRHYTHMIA ON (B)(6) 2020, FOLLOWING IMPLANT WITH THE ONXAAP (IMPLANTED (B)(6) 2020).

    Patient problems: Arrhythmia

    MAUDE report 16496304 ↗
  • InjuryFeb 13, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED, A PATIENT IN THE ASCEND STUDY WAS REPORTED TO HAVE A CARDIAC ARRHYTHMIA (III GRADE AV BLOCK) THAT RESULTED IN A REOPERATION. THIS INVESTIGATION WILL BE RELEGATED TO ONXAAP-27/29, SN (B)(4). THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT. THIS REPORT IS BEING SUBMITTED AS REQUIRED BY FEDERAL REGULATIONS AND DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. FURTHERMORE, THIS REPORT REFLECTS THE EVENT AS ALLEGED BY THE COMPLAINANT AND DOES NOT IMPLY THAT THE INFORMATION REPORTED TO ARTIVION IS ACCURATE OR HAS BEEN CONFIRMED BY ARTIVION.

    Patient problems: Heart Block

    MAUDE report 16364384 ↗
  • InjuryDec 12, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT (B)(6) IN THE ASCEND STUDY EXPERIENCED THREE (3) ADVERSE EVENTS THAT WERE POSSIBLY RELATED TO THE IMPLANTED ON-X VALVE [ONXAAP-27 /27 SN (B)(4)]: (B)(6) 2022: SEIZURE. (B)(6) 2022: CARDIAC ARRHYTHMIA. (B)(6) 2022: MEDIASTINAL HEMATOMA OVERLYING THE RIGHT VENTRICLE WITH COMPRESSION. THIS INVESTIGATION WILL BE RELEGATED TO THE (B)(6) 2022 EVENT.

    Patient problems: Hematoma; Pleural Effusion; Shock

    MAUDE report 15960829 ↗
  • InjuryDec 12, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT: (B)(6) IN THE ASCEND STUDY EXPERIENCED THREE (3) ADVERSE EVENTS THAT WERE POSSIBLY RELATED TO THE IMPLANTED ON-X VALVE [ONXAAP-27/27 SN: (B)(4)]: ON (B)(6) 2022: SEIZURE. ON (B)(6) 2022: CARDIAC ARRHYTHMIA. ON (B)(6) 2022: MEDIASTINAL HEMATOMA OVERLYING THE RIGHT VENTRICLE WITH COMPRESSION. THIS INVESTIGATION WILL BE RELEGATED TO THE ON (B)(6) 2022 EVENT.

    Patient problems: Arrhythmia

    MAUDE report 15960683 ↗
  • InjuryDec 12, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT (B)(6) IN THE ASCEND STUDY EXPERIENCED THREE (3) ADVERSE EVENTS THAT WERE POSSIBLY RELATED TO THE IMPLANTED ON-X VALVE [ONXAAP-27/27 SN (B)(4)]: (B)(6) 2022: SEIZURE; (B)(6) 2022: CARDIAC ARRHYTHMIA; (B)(6) 2022: MEDIASTINAL HEMATOMA OVERLYING THE RIGHT VENTRICLE WITH COMPRESSION. THIS INVESTIGATION WILL BE RELEGATED TO THE (B)(6) 2022 EVENT.

    Patient problems: Convulsion/Seizure

    MAUDE report 15960113 ↗
  • InjuryOct 24, 2022Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    ACCORDING TO INITIAL REPORTS, ASCEND - POST MARKET CLINICAL FOLLOW-UP STUDY IN PATIENTS TREATED WITH THE ON-X ASCENDING AORTIC PROSTHESIS (AAP). ADVERSE EVENT - PATIENT EXPERIENCED CARDIAC ARRHYTHMIA. DURATION OF THE EVENT (B)(6) 2020. SYMPTOMS RESOLVED WITHOUT SEQUELAE. CAUSAL RELATIONSHIP TO PROCEDURE - POSSIBLE. CAUSAL RELATIONSHIP TO THE AORTIC VALVE DISEASE OF HETEROGENEOUS ETHOLOGY - NOT RELATED. CAUSAL RELATIONSHIP TO ONXAAP - POSSIBLE. NO OTHER INFORMATION PROVIDED.

    Patient problems: Arrhythmia

    MAUDE report 15657553 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P000037. One submission often covers many models, so check the product and lot details in each record.

  • Z-2133-2026 · Feb 1, 2026 · Open, Classified
    On-X Mitral Heart Valve with Conform-X Sewing Ring, Model: ONXMC-25/33
  • Z-1073-2019 · Jan 17, 2019 · Terminated
    On-X Aortic Heart Valve with Anatomic Sewing Ring Product Usage: The On-X Prosthetic Heart Valve is indicated for the replacement of diseased, damaged, or malfunctioning native
  • Z-2715-2017 · Jun 12, 2015 · Terminated
    On-X Prosthetic Heart Valve Product Usage: Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic and mitral positio
  • Z-3108-2017 · Feb 12, 2014 · Terminated
    On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in th

Other Heart-Valve, Mechanical devices

All Heart-Valve, Mechanical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page